Tom Wilemon

October 4, 2018

Cochran celebrates cancer treatment’s end in style

Singer Anita Cochran had famous friends in the room when she celebrated her last cancer treatment, but the person with her who mattered the most was her 89-year-old father.

By Tom Wilemon
October 3, 2018

New study looks at brain networks involved in free will

Using lesion network mapping, a recently developed technique for analyzing how the brain works, Ryan Darby, MD, assistant professor of Neurology at Vanderbilt, studied free will perception related to movement decisions.

By Tom Wilemon
September 27, 2018

Cancer Moonshot award to help map tumor progression

A trans-institutional team of researchers at Vanderbilt University Medical Center and Vanderbilt University has received an $11 million Cancer Moonshot grant to build a single-cell resolution atlas to map out the routes that benign colonic polyps take to progress to colorectal cancer, the third most common cancer among both men and women in the United States.

By Tom Wilemon
September 27, 2018

Team’s potential lung cancer therapy lands award from SBIR

A potential cancer drug aimed at enhancing the effectiveness of ionizing radiation in lung cancer patients is a step closer to development with funding support from the Small Business Innovation Research (SBIR) program.

By Tom Wilemon
September 20, 2018

Chic Awearness event supports VUMC ovarian cancer research

The T.J. Martell Foundation’s 6th Annual Chic Awearness fundraising event that supports ovarian cancer research at Vanderbilt-Ingram Cancer Center will be held Monday, Sept. 24, 6:30 – 8:30 p.m.

By Tom Wilemon
September 20, 2018

CDC releases new mild traumatic brain injury guideline

The Centers for Disease Control and Prevention released new clinical recommendations for health care providers treating children with mild traumatic brain injury, often referred to as concussion.

By Tom Wilemon
September 13, 2018

Study tracks incidence, timing of immunotherapy-related deaths

Vanderbilt-Ingram Cancer Center researchers have answered questions about the incidence and timing of rare but sometimes fatal reactions to the most widely prescribed class of immunotherapies.
By Tom Wilemon
August 30, 2018

Major award seeks to improve stroke outcomes

Vanderbilt’s Kenneth Gaines, MD, MBA, professor of Clinical Neurology, has received a $15.7 funding award to determine if stroke outcomes can be improved with a redesigned and better-integrated model of care.
By Tom Wilemon
August 30, 2018

Parkinson’s study to track impact of DBS on earliest patients

A decade after taking part in the first clinical trial of deep brain stimulation (DBS) administered during very early-stage Parkinson’s disease, participants will return to Vanderbilt University Medical Center this year to be re-evaluated.
By Tom Wilemon
August 30, 2018

Study links aortic stiffness with lower cerebral blood flow

Greater aortic stiffness is related to lower cerebral blood flow, especially among individuals with increased genetic predisposition to Alzheimer’s disease, according to research from Vanderbilt University Medical Center.
By Tom Wilemon
August 14, 2018

Medically underserved women in the Southeast rarely receive BRCA tests

Medically underserved women in the Southeast diagnosed with breast cancer or ovarian cancer missed out on genetic testing that could have helped them and their relatives make important decisions about their health, according to new research from Vanderbilt-Ingram Cancer Center.
By Tom Wilemon
August 9, 2018

Radiation Oncology Survivorship Program adds telemedicine care

The Vanderbilt-Ingram Cancer Center Department of Radiation Oncology is offering survivorship care in Clarksville, Tennessee, via telemedicine to patients after they complete curative treatment.
By Tom Wilemon
1 … 27 28 29 30 31 … 39